Original Articles and Brief Reports

Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO ‘MDS-U’ designation

Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa
Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa;Clinical Laboratory Science, Kanazawa University Graduate School of Medical Science, Kanazawa
Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa
Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa;Tokyo Metropolitan Ohtsuka Hospital, Department of Internal Medicine, Toshima
Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa
Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa
Cancer Genomics Project, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
Cancer Genomics Project, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
Cancer Genomics Project, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa
Vol. 97 No. 12 (2012): December, 2012 https://doi.org/10.3324/haematol.2011.061127